`
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`______________
`
`Mylan Pharmaceuticals Inc.,
`Petitioner,
`
`v.
`
`Nissan Chemical Industries Ltd.,
`Patent Owner
`________________
`
`U.S. Patent No. 5,856,336
`
`Issue Date: January 5, 1999
`
`Title: Quinoline Type Mevalonolactones
`
`________________
`
`Inter Partes Review No. IPR2015-01069
`
`PATENT OWNER’S MANDATORY DISCLOSURES
`UNDER 37 C.F.R. § 42.8
`
`
`
`I.
`
`37 C.F.R. § 42.8(b)(1) – NOTICE OF REAL PARTY IN INTEREST
`
`The real parties in interest are Nissan Chemical Industries, Ltd., Kowa
`
`Company, Ltd., and Kowa Pharmaceuticals America, Inc.
`
`II.
`
`37 C.F.R. § 42.8(b)(2) – RELATED MATTERS
`
`Plaintiffs assert that defendants in the following litigations infringe the ‘336
`
`Patent: Kowa Company, Ltd., et. al. v. Amneal Pharmaceuticals, LLC, 1:14-cv-
`
`02758 (S.D.N.Y., April 17, 2014); Kowa Company, Ltd., et. al. v. Aurobindo
`
`Pharma Limited, et. al., 1:14-cv-02497 (S.D.N.Y., April; 9, 2014); Kowa
`
`Company, Ltd., et. al. v. Mylan, Inc., et. al., 1:14-cv-02647 (S.D.N.Y., April 14,
`
`2014); Kowa Company, Ltd., et. al. v. Orient Pharma Co., Ltd., 1:14-cv-02759
`
`(S.D.N.Y., April 17, 2014); Kowa Company, Ltd., et. al. v. Sawai USA, Inc, et. al.,
`
`1:14-cv-05575 (S.D.N.Y., July 23, 2014); and Kowa Company, Ltd., et. al. v.
`
`Zydus Pharmaceuticals (USA) Inc., et. al., 1:14-cv-02760 (S.D.N.Y., April 17,
`
`2014).
`
`III.
`
`37 C.F.R. § 42.8(b)(3) – LEAD AND BACKUP COUNSEL
`
`Lead Counsel: David G. Conlin (Reg. No. 27,026); Tel.: 617-348-1856;
`
`Fax: 617-542-2241; Address: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.,
`
`One Financial Center, Boston, MA 02111; email: DGConlin@mintz.com.
`
`
`
`Backup Counsel: Kathleen B. Carr (Reg. No. 41,658); Tel.: 617-348-1857;
`
`Fax: 617-542-2241; Address: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.,
`
`One Financial Center, Boston, MA 02111; email: KBCarr@mintz.com.
`
`IV.
`
`37 C.F.R. § 42.8(b)(4) – SERVICE INFORMATION
`
`Please direct all correspondence to lead counsel and backup counsel at the
`
`contact information above. Patent Owner consents to service by electronic mail at
`
`all of the following email addresses:
`
`DGConlin@mintz.com
`KBCarr@mintz.com
`
`Respectfully submitted,
`By:
`/Kathleen B. Carr/___________
`
`David G. Conlin, Reg. No. 27,026
`Kathleen B. Carr, Reg. No.41,658
`
`Mintz, Levin, Cohn, Ferris, Glovsky and
`Popeo, P.C.
`One Financial Center
`Boston, MA 02111
`617-542-6000
`617-542-2241 fax
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notice was served on May 8th, 2015 by sending a copy by
`
`overnight courier to:
`
`Jitendra Malik
`4721 Emperor Blvd., Suite 400
`Durham, North Carolina 27703
`
`and
`
`Deanne M. Mazzochi
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard St., Suite 500
`Chicago, Illinois 60654
`
`/Kathleen B. Carr/
`
`Kathleen B. Carr
`Reg. No. 41,658